Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease

被引:0
|
作者
Helabad, Mahdi Bagherpoor [1 ,2 ,3 ]
Matlahov, Irina [4 ]
Kumar, Raj [5 ]
Daldrop, Jan O. [6 ]
Jain, Greeshma [4 ]
Weingarth, Markus [5 ]
van der Wel, Patrick C. A. [4 ]
Miettinen, Markus S. [1 ,6 ,7 ,8 ]
机构
[1] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, D-14476 Potsdam, Germany
[2] Univ Leipzig, Inst Drug Discovery, Med Ctr, D-04103 Leipzig, Germany
[3] Martin Luther Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Saale, Germany
[4] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands
[5] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Chem, NMR Spect, NL-3584 CH Utrecht, Netherlands
[6] Free Univ Berlin, FACHBEREICH PHYS, D-14195 BERLIN, Germany
[7] Univ Bergen, Dept Chem, N-5007 Bergen, Norway
[8] Univ Bergen, Dept Informat, Computat Biol Unit, N-5008 Bergen, Norway
关键词
PARTICLE MESH EWALD; SOLID-STATE; AMYLOID FIBRILS; SIDE-CHAIN; POLYGLUTAMINE PEPTIDES; POLAR ZIPPERS; IN-VITRO; CRYO-EM; PROTEIN; AGGREGATION;
D O I
10.1038/s41467-024-55062-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurodegeneration in Huntington's disease (HD) is accompanied by the aggregation of fragments of the mutant huntingtin protein, a biomarker of disease progression. A particular pathogenic role has been attributed to the aggregation-prone huntingtin exon 1 (HTTex1), generated by aberrant splicing or proteolysis, and containing the expanded polyglutamine (polyQ) segment. Unlike amyloid fibrils from Parkinson's and Alzheimer's diseases, the atomic-level structure of HTTex1 fibrils has remained unknown, limiting diagnostic and treatment efforts. We present and analyze the structure of fibrils formed by polyQ peptides and polyQ-expanded HTTex1 in vitro. Atomic-resolution perspectives are enabled by an integrative analysis and unrestrained all-atom molecular dynamics (MD) simulations incorporating experimental data from electron microscopy (EM), solid-state NMR, and other techniques. Alongside the use of prior data, we report magic angle spinning NMR studies of glutamine residues of the polyQ fibril core and surface, distinguished via hydrogen-deuterium exchange (HDX). Our study provides a molecular understanding of the structure of the core as well as surface of aggregated HTTex1, including the fuzzy coat and polyQ-water interface. The obtained data are discussed in context of their implications for understanding the detection of such aggregates (diagnostics) as well as known biological properties of the fibrils.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's disease
    Bertoglio, Daniele
    Bard, Jonathan
    Hessmann, Manuela
    Liu, Longbin
    Gaertner, Annette
    De Lombaerde, Stef
    Huscher, Britta
    Zajicek, Franziska
    Miranda, Alan
    Peters, Finn
    Herrmann, Frank
    Schaertl, Sabine
    Vasilkovska, Tamara
    Brown, Christopher J.
    Johnson, Peter D.
    Prime, Michael E.
    Mills, Matthew R.
    Van der Linden, Annemie
    Mrzljak, Ladislav
    Khetarpal, Vinod
    Wang, Yuchuan
    Marchionini, Deanna M.
    Skinbjerg, Mette
    Verhaeghe, Jeroen
    Dominguez, Celia
    Staelens, Steven
    Munoz-Sanjuan, Ignacio
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (630)
  • [22] Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin
    Tan, Z.
    Dai, W.
    van Erp, T. G. M.
    Overman, J.
    Demuro, A.
    Digman, M. A.
    Hatami, A.
    Albay, R.
    Sontag, E. M.
    Potkin, K. T.
    Ling, S.
    Macciardi, F.
    Bunney, W. E.
    Long, J. D.
    Paulsen, J. S.
    Ringman, J. M.
    Parker, I.
    Glabe, C.
    Thompson, L. M.
    Chiu, W.
    Potkin, S. G.
    MOLECULAR PSYCHIATRY, 2015, 20 (11) : 1286 - 1293
  • [23] Structural Model of the Proline-Rich Domain of Huntingtin Exon-1 Fibrils
    Falk, Alexander S.
    Bravo-Arredondo, Jose M.
    Varkey, Jobin
    Pacheco, Sayuri
    Langen, Ralf
    Siemer, Ansgar B.
    BIOPHYSICAL JOURNAL, 2020, 119 (10) : 2019 - 2028
  • [24] Huntingtin exon 1 fibrils feature an interdigitated β-hairpin-based polyglutamine core
    Hoop, Cody L.
    Lin, Hsiang-Kai
    Kar, Karunakar
    Magyarfalvi, Gabor
    Lamley, Jonathan M.
    Boatz, Jennifer C.
    Mandal, Abhishek
    Lewandowski, Jozef R.
    Wetzel, Ronald
    van der Wel, Patrick C. A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (06) : 1546 - 1551
  • [25] Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease
    Chen, Mingchen
    Wolynes, Peter G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (17) : 4406 - 4411
  • [26] Natural Osmolytes Remodel the Aggregation Pathway of Mutant Huntingtin Exon 1
    Borwankar, Tejas
    Roethlein, Christoph
    Zhang, Gong
    Techen, Anne
    Dosche, Carsten
    Ignatova, Zoya
    BIOCHEMISTRY, 2011, 50 (12) : 2048 - 2060
  • [27] Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington's Disease
    Osmand, Alexander P.
    Bichell, Terry Jo.
    Bowman, Aaron B.
    Bates, Gillian P.
    JOURNAL OF HUNTINGTONS DISEASE, 2016, 5 (04) : 343 - 346
  • [28] Analysis of mutant and total huntingtin expression in Huntington's disease murine models
    Fodale, Valentina
    Pintauro, Roberta
    Daldin, Manuel
    Altobelli, Roberta
    Spiezia, Maria Carolina
    Bisbocci, Monica
    Macdonald, Douglas
    Bresciani, Alberto
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [29] Allele-Specific Silencing of Mutant Huntingtin for Huntington's Disease Therapy
    Mas-Monteys, Alex
    Harper, Scott Q.
    Gilmore, Brian L.
    Staber, Patrick D.
    Schaffer, Chris
    Polisky, Barry
    Vargeese, Chandra
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2006, 13 : S274 - S275
  • [30] VALIDATION OF SUPPRESSORS OF MUTANT HUNTINGTIN TOXICITY IN A FLY MODEL OF HUNTINGTON'S DISEASE
    Casu, M.
    Campesan, S.
    Clapp, J.
    Kyriacou, C. P.
    Giorgini, F.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A11 - A11